Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

10.03
+0.75438.13%
Volume:231.72K
Turnover:2.23M
Market Cap:61.33M
PE:-0.19
High:10.03
Open:9.58
Low:9.26
Close:9.28
52wk High:309.60
52wk Low:8.99
Shares:6.11M
Float Shares:3.83M
Volume Ratio:6.30
T/O Rate:6.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-51.9692
EPS(LYR):-59.6431
ROE:-783.37%
ROA:-62.39%
PB:-0.65
PE(LYR):-0.17

Loading ...

Chardan Initiates Gossamer Bio at Buy With $160 Price Target

MT Newswires Live
·
5 hours ago

Gossamer Bio initiated with a Buy at Chardan

TIPRANKS
·
5 hours ago

Gossamer Bio submits New Drug Application to FDA for seralutinib

TIPRANKS
·
Sep 24

Gossamer Bio Submits FDA NDA for Seralutinib in Pulmonary Arterial Hypertension

Reuters
·
Sep 24

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

THOMSON REUTERS
·
Sep 24

Gossamer Bio, - FDA to Determine Nda Acceptance for Filing Later This Year

THOMSON REUTERS
·
Sep 24

Gossamer Bio Director Gregory Austin Ciongoli Files Initial Beneficial Ownership Statement

Reuters
·
Sep 23

Gossamer Bio, Inc. : H.c. Wainwright Adjusts Target Price to $90 to Reflect 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 21

US Research Roundup-eBay, Sunbelt Rentals, T-Mobile

Reuters
·
Sep 21

Gossamer Bio Appoints Greg Ciongoli to Board, Names Him to Audit Committee

Reuters
·
Sep 17

Gossamer Bio Appoints Greg Ciongoli to Board of Directors

THOMSON REUTERS
·
Sep 17

Gossamer Bio Effects 1-for-80 Reverse Stock Split

Reuters
·
Sep 11

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 11

Gossamer Bio trading halted, news pending

TIPRANKS
·
Sep 11

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Sep 11

Gossamer Bio Announces 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 09

Gossamer Bio Highlights Seralutinib Phase 3 Prosera Data, Targets PAH NDA Filing

Reuters
·
Sep 08

Gossamer Bio to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 04

Gossamer Bio - Board Approves Amendment and Restatement of Bylaws Effective Sept 3, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 04

Gossamer Bio Cuts Shareholder Meeting Quorum Requirement to One-Third of Voting Power

Reuters
·
Sep 04